Skip to content

Innovation in medicines: adapting for the future

Free event
This is a past event, catch up below

Never has scientific research looked as promising as it does now, with new exciting possibilities for tackling diseases through the development of innovative medicines. The process, from research to use, takes several years and requires the close collaboration of many stakeholders. What is the role of each part of the system – from industry researcher, through the regulating medicines authorities, to NHS clinicians and patients? And, given their differing perspectives, how do these different parts of the system view the future of innovation in research, medicines and the NHS?

This event explored the process of developing new medicines and discussed what access and uptake entail, with experts on hand to answer questions and clarify how the system works at the moment.  We discussed the best way forward to make the most of innovation, while maintaining patient safety and clinical standards.

Watch back on demand

Please note, this event was pre-recorded and our speakers were watching along and answered the most popular questions during the livestream on 21st September.  The content was pre-recorded before the September 2021 government reshuffle.

Get in touch about sponsorship and exhibition

If you would like a conversation about your business goals, and how being involved with future events can help you, please email the Partnerships team.


  • Paula Head photo

    Paula Head

    Senior Fellow
  • Lord Bethell photo

    Lord Bethell of Romford

    Former Parliamentary Under Secretary of State (Minister for Innovation)
  • Paul Catchpole photo

    Paul Catchpole

    Value and Access Policy Director, Association of the British Pharmaceutical Industry (ABPI)
  • Nick Meade photo

    Nick Meade

    Joint Interim Chief Executive and Director of Policy, Genetic Alliance UK
  • Sharmila Nebhrajani photo

    Sharmila Nebhrajani OBE

    Chairman, National Institute for Health and Care Excellence
  • Olivia Rossanese photo

    Dr Olivia Rossanese

    Interim Director of the Cancer Research UK Cancer Therapeutics Unit and Interim Head of the Division of Cancer Therapeutics, The Institute of Cancer Research